Ruxolitinib (Jakavi®)
-
Traffic LightRed
-
BNF8.1.5
-
Licensed IndicatorsMyelofibrosis, either primary in origin or following other related disorders such as polycythaemia
-
ReferenceAPC Dec 12
-
ProvisionalYes
Do you want to add this to your CPD record?
Did you find this page helpful?